herenciageneticayenfermedad: Pulmonology

jueves, 14 de diciembre de 2017

Pulmonology - Dec 12, 2017 Edition

	December 12, 2017
	Pulmonology
	The latest pulmonology news from News Medical

	Hospitals find asthma hot spots more profitable to neglect than fix Keyonta Parnell has had asthma most of his young life, but it wasn't until his family moved to the 140-year-old house here on Lemmon Street two years ago that he became one of the health care system's frequent customers.

	NICE releases the latest asthma management standards In 2016 in England and Wales alone, a shocking 1,237 people died from an asthma attack2. On November 29th 2017, NICE published the final guidelines on Asthma: diagnosis, monitoring and chronic asthma management, to improve asthma care, which included the NObreath® FeNO monitor from local manufacturer and second-generation family company, Bedfont Scientific Ltd., as a recommended device.

			Synthetic cannabis-like drug found to be safe and effective in treating sleep apnea A synthetic cannabis-like drug in a pill was safe and effective in treating obstructive sleep apnea in the first large multi-site study of a drug for apnea funded by the National Institutes of Health. The study was conducted at Northwestern Medicine and the University of Illinois at Chicago.

			Childhood asthma linked to high maternal sugar intake during pregnancy New research published today in the Annals of the American Thoracic Society reports that children born to mothers who drank a lot of sugary drinks during pregnancy may be at an increased risk of developing asthma during childhood.

			Family risk for childhood asthma may involve microbes found in baby's digestive tract A new University of Alberta study shows that the family risk for asthma--typically passed from moms to babies--may not be a result of genetics alone: it may also involve the microbes found in a baby's digestive tract.

	Prenatal and early-life consumption of sugary drinks may increase risk of mid-childhood asthma Children between the ages of 7 and 9 may be at greater risk for developing asthma if they consumed high amounts of fructose in early childhood or their mothers drank a lot of sugar-sweetened beverages while pregnant, according to new research published online in the Annals of the American Thoracic Society.

	Study: Fewer new cases of lung cancer found in communities with strong smoke-free laws A recent study by University of Kentucky BREATHE researchers shows that fewer new cases of lung cancer were found in communities with strong smoke-free workplace laws.

	Study provides potential explanation for increased prevalence of asthma in adult women In childhood, asthma is more common in boys than girls. But around the time of puberty, that picture reverses. By midlife women are twice as likely as men to have asthma.

	'Aggressive' surgery for early stage lung cancer provides better outcomes Patients with early stage lung cancer live longer when they receive a lobectomy- the most common type of operation for the disease- rather than a less extensive operation or radiation treatment, according to a study published online today in The Annals of Thoracic Surgery.

	Attack on asthma: Scrubbing homes of allergens may tame disease and its costs After years of studying the causes of asthma, a pediatrician-turned-public health sleuth thinks there's a way to substantially reduce its impact.

	New report reveals steep rise in lung disease admissions to emergency departments during winter An 80% rise in lung disease admissions to emergency departments in winter plays a major part in pushing our A&E services over the edge. Yet, only 10% of hospital trusts who responded to an FOI request had plans in place to make more beds available for respiratory patients warns a new report from the British Lung Foundation.

	Researchers identify promising solution for improving cystic fibrosis treatments Researchers at the University of Montreal Hospital Research Centre have identified a promising solution to improving treatments offered to patients with cystic fibrosis.

	Study shows safety, efficacy of cystic fibrosis drug in children between 1 to 2 years of age Ann & Robert H. Lurie Children's Hospital of Chicago is one of the study sites in the open label Phase 3 study that showed safety and effectiveness of the cystic fibrosis drug Kalydeco (ivacaftor) in children ages 1 to 2 years.

	Prior smoking exposure linked to potential risks of wheeze and asthma in children In a Pediatric Pulmonology study of children aged 15 months, increasing hair nicotine levels were related to prior parent-reported smoking exposure and were associated with potential increased risks of wheeze and asthma.

	Intestinal worms have influence on allergy and asthma risk in humans While young people with parasite worms currently have four times higher risk for developing allergies and asthma than others. Their parents are generally unaffected.

	Children with high blood levels of polyunsaturated fatty acids less likely to develop asthma or rhinitis New research from Karolinska Institutet in Sweden reveals that high levels of polyunsaturated fatty acids in children's blood are associated with a reduced risk of asthma or rhinitis at the age of 16 years. The study is published in The Journal of Allergy and Clinical Immunology.

	Novel drug combination could enhance immunotherapy responses in patients with lung cancer Johns Hopkins Kimmel Cancer Center researchers and colleagues have identified a novel drug combination therapy that could prime nonsmall cell lung cancers to respond better to immunotherapy.

	Severely preterm children with HRV have lower airway obstruction linked to retractions, wheezing Human rhinovirus (HRV), the culprit behind most colds, is the leading cause of hospitalization for premature babies. However, in very preterm children, exactly how HRV causes severe respiratory disease -- and which patients may need more intensive observation and treatment -- is less well understood.

	Hyperbaric oxygen therapy can improve pathology of Alzheimer's disease, study shows A new Tel Aviv University study reveals that hyperbaric oxygen treatments may ameliorate symptoms experienced by patients with Alzheimer's disease.

	Study suggests novel approach to predict respiratory allergy in children A new study in EBioMedicine by researchers at Karolinska Institutet in Sweden and the Medical University of Vienna, Austria suggests that immune response in early childhood to a handful of allergen molecules can predict the onset of allergic rhinitis and asthma in adolescence.

	New first line combination therapy shows promising results in patients with advanced NSCLC A new combination therapy for the first line treatment of advanced non-squamous non-small-cell lung cancer (NSCLC) improves progression-free survival (PFS), according to results of phase III IMpower150 trial presented at the ESMO Immuno Oncology Congress 2017.

	Nearly 3 in 10 elite footballers at top clubs have undetected lung and airway problems, study finds New research from the University of Kent has discovered that nearly three in 10 elite footballers at top clubs in England have undetected lung and airway problems that could impair their on-field performance.

	UT Southwestern researchers identify potential approach to suppress lethal parasitic infections UT Southwestern Medical Center researchers have identified a chemical that suppresses the lethal form of a parasitic infection caused by roundworms that affects up to 100 million people and usually causes only mild symptoms.

	NYU Langone Health launches new heart transplant program The Transplant Institute at NYU Langone Health has launched a new heart transplant program-;the first new program of its kind in New York State in more than 15 years.

	Immune-boosting drug combination may hold promise for treating ovarian cancer Johns Hopkins Kimmel Cancer Center researchers demonstrated that mice with ovarian cancer that received drugs to reactivate dormant genes along with other drugs that activate the immune system had a greater reduction of tumor burden and significantly longer survival than those that received any of the drugs alone.

	MIT researchers discover new way to make bacteria vulnerable to existing antibiotics MIT researchers have discovered a way to make bacteria more vulnerable to a class of antibiotics known as quinolones, which include ciprofloxacin and are often used to treat infections such as Escherichia coli and Staphylococcus aureus.